Skip to content
Friday, June 19, 2026
Latest:
  • Wastewater analysis offers a new way to monitor HIV in communities
  • Growing Up Baylor: Dr. Afroze Ali
  • Diet remodels chromatin structure and extends survival in models of glioma
  • Manage your sweets this summer
  • When can children go out by themselves?
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Aries Payne
      • Andy Phifer
      • Homa Warren
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

TNBC

From The Labs

Serendipity reveals an opportunity to improve the success of chemotherapy in triple negative breast cancer

July 27, 2023 kinase inhibitor,  KIPA,  purine-binding protein,  Research,  TNBC,  triple-negative breast cancer

Researchers identified a tumor protein signature that predicts chemotherapy sensitivity and favorable clinical outcomes.

Read More

From the Labs: Image of the Month

two distinct neuronal populations in separate compartments of a microfluidic device. On the left, neurons express the 4R tau form (pink), which is associated with toxicity in Alzheimer’s disease, while on the right there are neurons from healthy individuals expressing normal tau (blue). In the central microgroove region of the device, neurons extend axons between the compartments. From the Labs: Tau travels between neurons

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951